Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:48 pm Unchanged |
2025-03-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Great Point Partners, LLC | 2,055,834 6.650% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:47 pm Unchanged |
2025-03-31 | 13G | Outlook Therapeutics, Inc. OTLK |
Great Point Partners, LLC | 2,220,000 6.370% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:45 pm Sale |
2025-03-31 | 13G | OptiNose, Inc. OPTN |
Great Point Partners, LLC | 526,315 4.940% |
-370,270 (-41.30%) |
Filing History |
| 2025-05-15 4:44 pm Unchanged |
2025-03-31 | 13G | Context Therapeutics Inc. CNTX |
Great Point Partners, LLC | 4,683,711 5.220% |
0 (Unchanged) |
Filing History |
| 2025-05-14 4:11 pm Unchanged |
2025-05-08 | 13G | Zura Bio Limited ZURA |
Great Point Partners, LLC | 3,170,194 5.120% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:40 pm Sale |
2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Great Point Partners, LLC | 2,055,834 6.880% |
-674,075 (-24.69%) |
Filing History |
| 2025-02-14 4:39 pm Purchase |
2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Great Point Partners, LLC | 11,473,166 9.990% |
1,950,734 (+20.49%) |
Filing History |
| 2025-02-14 4:39 pm Purchase |
2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN |
Great Point Partners, LLC | 3,334,520 9.990% |
327,337 (+10.89%) |
Filing History |
| 2025-02-14 4:38 pm Sale |
2024-12-31 | 13G | Outlook Therapeutics, Inc. OTLK |
Great Point Partners, LLC | 2,220,000 8.180% |
-261,973 (-10.56%) |
Filing History |
| 2025-02-14 4:37 pm Purchase |
2024-12-31 | 13G | OptiNose, Inc. OPTN |
Great Point Partners, LLC | 896,585 8.470% |
896,585 (New Position) |
Filing History |
| 2025-02-14 4:33 pm Sale |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Great Point Partners, LLC | 4,683,711 6.250% |
-2,251,271 (-32.46%) |
Filing History |
| 2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Zura Bio Limited ZURA |
Great Point Partners, LLC | 3,170,194 4.860% |
-93,478 (-2.86%) |
Filing History |
| 2025-02-14 4:31 pm Sale |
2024-12-31 | 13G | Neurogene Inc. NGNE |
Great Point Partners, LLC | 442,761 2.980% |
-561,530 (-55.91%) |
Filing History |
| 2024-11-14 5:06 pm Sale |
2024-09-30 | 13G | Zura Bio Limited ZURA |
Great Point Partners, LLC | 3,263,672 5.120% |
-31,328 (-0.95%) |
Filing History |
| 2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
Great Point Partners, LLC | 2,729,909 9.380% |
-63,018 (-2.26%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Great Point Partners, LLC | 9,522,432 9.990% |
963,432 (+11.26%) |
Filing History |
| 2024-11-14 4:56 pm Purchase |
2024-09-30 | 13G | ProMIS Neurosciences, Inc. PMN |
Great Point Partners, LLC | 3,007,183 9.990% |
1,485 (+0.05%) |
Filing History |
| 2024-11-14 4:55 pm Purchase |
2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK |
Great Point Partners, LLC | 2,481,973 9.990% |
250,649 (+11.23%) |
Filing History |
| 2024-11-14 4:54 pm Purchase |
2024-09-30 | 13G | OptiNose, Inc. OPTN |
Great Point Partners, LLC | 1,020,463 9.990% |
254,855 (+33.29%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Neurogene Inc. NGNE |
Great Point Partners, LLC | 1,004,291 7.730% |
10,062 (+1.01%) |
Filing History |